PL2054405T3 - Nowe pochodne biarylobenzimidazolu i zawierająca je kompozycja farmaceutyczna - Google Patents
Nowe pochodne biarylobenzimidazolu i zawierająca je kompozycja farmaceutycznaInfo
- Publication number
- PL2054405T3 PL2054405T3 PL07768695T PL07768695T PL2054405T3 PL 2054405 T3 PL2054405 T3 PL 2054405T3 PL 07768695 T PL07768695 T PL 07768695T PL 07768695 T PL07768695 T PL 07768695T PL 2054405 T3 PL2054405 T3 PL 2054405T3
- Authority
- PL
- Poland
- Prior art keywords
- same
- pharmaceutical composition
- benzoimidazole derivatives
- novel biaryl
- biaryl benzoimidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20060065115 | 2006-07-11 | ||
| PCT/KR2007/003362 WO2008007900A1 (en) | 2006-07-11 | 2007-07-11 | Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| EP07768695.4A EP2054405B1 (en) | 2006-07-11 | 2007-07-11 | Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2054405T3 true PL2054405T3 (pl) | 2014-03-31 |
Family
ID=38923421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07768695T PL2054405T3 (pl) | 2006-07-11 | 2007-07-11 | Nowe pochodne biarylobenzimidazolu i zawierająca je kompozycja farmaceutyczna |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8436022B2 (pl) |
| EP (1) | EP2054405B1 (pl) |
| JP (1) | JP5054770B2 (pl) |
| CN (1) | CN101490037B (pl) |
| AU (1) | AU2007273333B2 (pl) |
| CA (1) | CA2656810C (pl) |
| ES (1) | ES2438240T3 (pl) |
| MY (1) | MY157033A (pl) |
| NZ (1) | NZ574697A (pl) |
| PL (1) | PL2054405T3 (pl) |
| PT (1) | PT2054405E (pl) |
| WO (1) | WO2008007900A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103450077B (zh) | 2007-06-08 | 2016-07-06 | 满康德股份有限公司 | IRE-1α抑制剂 |
| BRPI0905952A2 (pt) | 2008-02-04 | 2015-06-30 | Mercury Therapeutics | Composto e sais do mesmo e compição farmacêutica |
| MY152022A (en) * | 2008-04-18 | 2014-08-15 | Dae Woong Pharma | A novel benzoxazine benzimidazole derivatives, a pharmaceutical composition comprising the same, and a use thereof |
| KR101689421B1 (ko) | 2009-12-30 | 2016-12-23 | 아르퀼 인코포레이티드 | 치환된 이미다조피리디닐-아미노피리딘 화합물 |
| CN103180308B (zh) | 2010-09-28 | 2015-04-08 | 大熊制药株式会社 | 制备苯并咪唑衍生物的方法 |
| KR101293384B1 (ko) * | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 |
| WO2012061169A1 (en) * | 2010-11-01 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Benzimidazole inhibitors of leukotriene production |
| WO2012177852A1 (en) | 2011-06-24 | 2012-12-27 | Arqule, Inc | Substituted imidazopyridinyl compounds |
| CA2837727C (en) | 2011-06-24 | 2019-12-03 | Arqule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| SI3083627T1 (sl) | 2013-12-19 | 2019-01-31 | Novartis Ag | Derivati (1,2,4)triazolo(1,5-a)pirimidina kot inhibitorji protozoan proteasoma za zdravljenje parazitskih bolezni, kot je lišmanioza |
| US20170216252A1 (en) * | 2014-07-11 | 2017-08-03 | Simon Fraser University | Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods |
| ES2884902T3 (es) * | 2017-05-02 | 2021-12-13 | Bayer Ag | Derivados de heterociclos condensados sustituidos con 2-(het)arilo como pesticidas |
| WO2018202494A1 (de) * | 2017-05-02 | 2018-11-08 | Bayer Aktiengesellschaft | 2-(het)aryl-substituierte kondensierte heterocyclen-derivate als schädlingsbekämpfungsmittel |
| JPWO2019124529A1 (ja) * | 2017-12-22 | 2020-12-24 | 住友化学株式会社 | 複素環化合物及びそれを含有する有害節足動物防除剤 |
| EP4056560A1 (en) | 2018-03-08 | 2022-09-14 | Incyte Corporation | Aminopyrazine diol compounds as pi3k-y inhibitors |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| TW202124380A (zh) * | 2019-11-13 | 2021-07-01 | 日商日本新藥股份有限公司 | 功能性腸胃道障礙及口腔乾燥症之治療劑及預防劑 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200000098A1 (ru) * | 1997-08-05 | 2000-08-28 | Пфайзер Продактс Инк. | 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y |
| CA2330557A1 (en) | 1998-05-12 | 1999-11-18 | Robert Emmett Mcdevitt | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| JP2001039034A (ja) * | 1999-08-03 | 2001-02-13 | Mitsui Chemicals Inc | 光記録媒体 |
| AU2079901A (en) | 1999-12-06 | 2001-06-12 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| GB0017256D0 (en) * | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| ES2292812T3 (es) | 2001-10-19 | 2008-03-16 | Ortho-Mcneil Pharmaceutical, Inc. | 2-fenil benzimidazol e imidazo-(4,5)-piridinas como inhibidores de cds1/chk2 y coadyuvantes para quimioterapia o radioterapia en el tratamiento del cancer. |
| US6972281B2 (en) * | 2002-02-07 | 2005-12-06 | University Of Ottawa | Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| EP1501514B1 (en) | 2002-05-03 | 2012-12-19 | Exelixis, Inc. | Protein kinase modulators and methods of use |
| BR0313352A (pt) * | 2002-07-31 | 2005-07-12 | Euro Celtique Sa | Composto, composições farmacêuticas, método para a produção de um composto, método para o tratamento, prevenção ou a melhora de um distúrbio e método para o tratamento de um mamìfero |
| EP1590339A4 (en) | 2003-01-28 | 2007-07-25 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
| US7777051B2 (en) | 2003-05-13 | 2010-08-17 | Icagen, Inc. | Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| EP1682518A4 (en) | 2003-10-24 | 2007-08-01 | Univ North Carolina | DIKATIONAL TRIARYLANALOGA AS MEANS AGAINST PROTOZOEN |
| WO2006000020A1 (en) | 2004-06-29 | 2006-01-05 | European Nickel Plc | Improved leaching of base metals |
| WO2006080821A1 (en) | 2005-01-28 | 2006-08-03 | Daewoong Pharmaceutical Co., Ltd. | Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| KR101280096B1 (ko) | 2005-06-29 | 2013-06-28 | 컴퓨메딕스 리미티드 | 전도성 브리지를 포함하는 센서 어셈블리 |
| WO2007034277A1 (en) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists |
| TW200736229A (en) * | 2005-11-15 | 2007-10-01 | Abbott Lab | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors |
-
2007
- 2007-07-11 CA CA2656810A patent/CA2656810C/en active Active
- 2007-07-11 WO PCT/KR2007/003362 patent/WO2008007900A1/en active Application Filing
- 2007-07-11 PT PT77686954T patent/PT2054405E/pt unknown
- 2007-07-11 MY MYPI20090092A patent/MY157033A/en unknown
- 2007-07-11 ES ES07768695.4T patent/ES2438240T3/es active Active
- 2007-07-11 NZ NZ574697A patent/NZ574697A/en not_active IP Right Cessation
- 2007-07-11 JP JP2009519377A patent/JP5054770B2/ja active Active
- 2007-07-11 US US12/373,193 patent/US8436022B2/en active Active
- 2007-07-11 AU AU2007273333A patent/AU2007273333B2/en not_active Ceased
- 2007-07-11 CN CN2007800260153A patent/CN101490037B/zh active Active
- 2007-07-11 PL PL07768695T patent/PL2054405T3/pl unknown
- 2007-07-11 EP EP07768695.4A patent/EP2054405B1/en active Active
-
2013
- 2013-04-05 US US13/857,304 patent/US8940769B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101490037B (zh) | 2013-06-12 |
| CN101490037A (zh) | 2009-07-22 |
| US8940769B2 (en) | 2015-01-27 |
| EP2054405A1 (en) | 2009-05-06 |
| ES2438240T3 (es) | 2014-01-16 |
| PT2054405E (pt) | 2013-12-24 |
| US8436022B2 (en) | 2013-05-07 |
| NZ574697A (en) | 2011-12-22 |
| AU2007273333B2 (en) | 2010-07-08 |
| CA2656810A1 (en) | 2008-01-17 |
| JP5054770B2 (ja) | 2012-10-24 |
| EP2054405B1 (en) | 2013-09-18 |
| JP2009542802A (ja) | 2009-12-03 |
| US20130217684A1 (en) | 2013-08-22 |
| MY157033A (en) | 2016-04-15 |
| AU2007273333A1 (en) | 2008-01-17 |
| WO2008007900A1 (en) | 2008-01-17 |
| US20090209540A1 (en) | 2009-08-20 |
| EP2054405A4 (en) | 2011-01-19 |
| CA2656810C (en) | 2012-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2054405A4 (en) | NOVEL BIARYL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
| EP1861387A4 (en) | NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
| HK1221252A1 (zh) | 限制的 肽及含有其的藥物組合物 | |
| IL192965A0 (en) | Amido compounds and their use as pharmaceuticals | |
| IL196168A0 (en) | Biaryl compounds and pharmaceutical compositions containing the same | |
| IL242883B (en) | Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them | |
| EP1857489A4 (en) | MICROPARTICLE AND PHARMACEUTICAL COMPOSITION | |
| HUS1800034I1 (hu) | Anti-FGF23 ellenanyag és anti-FGF23 ellenanyagot tartalmazó gyógyászati készítmény | |
| AP2009004960A0 (en) | Co-crystals and pharmaceutical compositions comprising the same | |
| EP2056835A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| EP1890677A4 (en) | PHARMACEUTICAL COMPOSITIONS AND THEIR USE | |
| HK1141312A1 (en) | Cdca1 peptide and pharmaceutical agent comprising the same cdca1 | |
| GB0516069D0 (en) | Pharmaceutical and use thereof | |
| EP2147671A4 (en) | COMPOSITION WITH L-CARNITINE OR DERIVATIVES AND THEIR USE | |
| IL179669A0 (en) | Benzoimidazole derivatives and pharmaceutical compositions containing the same | |
| GB0614365D0 (en) | Pharmaceutical compositions and their use | |
| HK1108636A1 (en) | Substituted acrylamide derivative and pharmaceutical composition comprising the same | |
| HK1145837A1 (en) | Amide derivative and pharmaceutical composition containing the same | |
| EP2233467A4 (en) | ALPHA-AMINO N-SUBSTITUTED AMIDES, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USES THEREOF | |
| EP1908466A4 (en) | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
| EP1937292A4 (en) | LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| ZA200900960B (en) | Arylpiperazine derivatives and uses thereof | |
| AP2734A (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
| ZA200806638B (en) | Amido compounds and their use as pharmaceuticals | |
| GB0701295D0 (en) | Z-stilbenes derivatives and the pharmaceutical composition thereof |